George J Morrow insider trades: Neurocrine Biosciences (NBIX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where George reports to the SEC
and 1 more company
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | NBIX | ↓ Sell | 15,000 | $155.73 | $2.3M | Direct | Nov 3, 2026 (0d) |
| Nov 25, 2025 | NBIX | ↓ Sell | 15,000 | $143.37 | $2.2M | Direct | Nov 26, 2025 (1d) |
| Mar 14, 2024 | NBIX | ↓ Sell | 40,000 | $139.42 | $5.6M | Direct | Mar 15, 2024 (1d) |
| Aug 2, 2021 | ALGN | ↓ Sell | 5,000 | $707.34 | $3.5M | By Family Trust | Aug 3, 2021 (1d) |
| Feb 8, 2021 | ALGN | ↓ Sell | 15,000 | $624.60 | $9.4M | Direct | Feb 8, 2021 (0d) |
| Nov 4, 2020 | ALGN | ↓ Sell | 5,000 | $480.03 | $2.4M | Direct | Nov 4, 2020 (0d) |
| Oct 26, 2020 | ALGN | ↓ Sell | 20,000 | $466.05 | $9.3M | Direct | Oct 28, 2020 (2d) |
| May 23, 2016 | ALGN | ↓ Sell | 50,000 | $77.72 | $3.9M | Direct | May 24, 2016 (1d) |
| Oct 22, 2013 | ALGN | ↓ Sell | 75,000 | $57.27 | $4.3M | Direct | Oct 23, 2013 (1d) |
| May 23, 2013 | VICL | ↑ Buy | 5,953 | $0.01 | $60 | Direct | May 28, 2013 (5d) |
| Oct 15, 2012 | VICL | ↑ Buy | 6,394 | $0.01 | $64 | Direct | Oct 17, 2012 (2d) |
| Aug 5, 2011 | HGSI | ↑ Buy | 10,000 | $15.79 | $158K | Direct | Aug 9, 2011 (4d) |
| Jun 9, 2009 | AMGN | ↓ Sell | 21,000 | $51.07 | $1.1M | Direct | Jun 10, 2009 (1d) |
| Oct 24, 2008 | AMGN | ↓ Sell | 57,394 | $54.48 | $3.1M | Direct | Oct 28, 2008 (4d) |
| May 15, 2008 | ALGN | ↑ Buy | 5,000 | $12.63 | $63K | Direct | May 16, 2008 (1d) |
| Dec 7, 2007 | AMGN | ↑ Buy | 2,025 | $69.97 | $142K | By 401(k) Plan | Dec 11, 2007 (4d) |
| Jul 25, 2005 | AMGN | ↓ Sell | 303,335 | $81.11 | $24.6M | Direct | Jul 26, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NBIX insiders
Open-market trades in the last 12 months
About George J Morrow's insider trades
George J Morrow is a director at Neurocrine Biosciences (NBIX). Since Jul 25, 2005, George has reported 5 open-market purchases worth $363K and 12 sales worth $71.7M on SEC Form 4. In the last 12 months: 2 sales ($4.5M).
Their filings also include grants and awards (70 filings), option exercises (24 filings), conversions (7 filings), shares withheld for taxes (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NBIX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.